ES2191721T3 - Microparticulas reticuladas y su utilizacion como vehiculos terapeuticos. - Google Patents

Microparticulas reticuladas y su utilizacion como vehiculos terapeuticos.

Info

Publication number
ES2191721T3
ES2191721T3 ES95940381T ES95940381T ES2191721T3 ES 2191721 T3 ES2191721 T3 ES 2191721T3 ES 95940381 T ES95940381 T ES 95940381T ES 95940381 T ES95940381 T ES 95940381T ES 2191721 T3 ES2191721 T3 ES 2191721T3
Authority
ES
Spain
Prior art keywords
microparticles
reticulated
vehicles
water
therapeutic vehicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95940381T
Other languages
English (en)
Inventor
Richard Alan Johnson
Andrew Derek Sutton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Elan Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Drug Delivery Ltd filed Critical Elan Drug Delivery Ltd
Application granted granted Critical
Publication of ES2191721T3 publication Critical patent/ES2191721T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

POLVO ESTERIL FORMADO POR MICROPARTICULAS DE 0,1 A 50 MI}M DE DIAMETRO, OBTENIDAS MEDIANTE DESHIDRATACION POR ASPERSION Y FORMACION DE ENLACES CRUZADOS DE UN MATERIAL HIPOSOLUBLE CON GRUPOS FUNCIONALES LIBRES, QUE SE CARACTERIZA POR QUE LAS MICROPARTICULAS SON HIDROFILICAS, PUEDE RECONSTITUIRSE EN AGUA PARA OBTENER UNA SUSPENSION MONODISPERSA Y CONSERVA DICHOS GRUPOS DISPONIBLES PARA LA DERIVATIZACION. LAS PARTICULAS SE UNEN A FARMACOS O A OTRAS MOLECULA FUNCIONALES Y SE UTILIZAN COMO EXCIPIENTES TERAPEUTICOS.
ES95940381T 1994-12-16 1995-12-14 Microparticulas reticuladas y su utilizacion como vehiculos terapeuticos. Expired - Lifetime ES2191721T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94309417 1994-12-16

Publications (1)

Publication Number Publication Date
ES2191721T3 true ES2191721T3 (es) 2003-09-16

Family

ID=8217949

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95940381T Expired - Lifetime ES2191721T3 (es) 1994-12-16 1995-12-14 Microparticulas reticuladas y su utilizacion como vehiculos terapeuticos.

Country Status (19)

Country Link
EP (1) EP0796090B1 (es)
JP (1) JP4350165B2 (es)
CN (1) CN1175208A (es)
AT (1) ATE234080T1 (es)
AU (1) AU692019B2 (es)
BR (1) BR9510462A (es)
CA (1) CA2207077C (es)
CZ (1) CZ183797A3 (es)
DE (1) DE69529917T2 (es)
DK (1) DK0796090T3 (es)
ES (1) ES2191721T3 (es)
FI (1) FI972546A (es)
HU (1) HUT77369A (es)
NO (1) NO972554L (es)
NZ (1) NZ297072A (es)
PL (1) PL321018A1 (es)
PT (1) PT796090E (es)
WO (1) WO1996018388A2 (es)
ZA (1) ZA9510702B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5955108A (en) * 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
WO1997044015A1 (en) * 1996-05-17 1997-11-27 Andaris Limited Microparticles and their use in wound therapy
GB9610830D0 (en) 1996-05-23 1996-07-31 Andaris Ltd Use of hollow microcapsules
GB9615435D0 (en) * 1996-07-23 1996-09-04 Andaris Ltd Spray-dried product and its therapeutic use
AU4713497A (en) * 1996-10-19 1998-05-15 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules in diagnosis and therapy
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
ATE284714T1 (de) * 1996-10-21 2005-01-15 Quadrant Drug Delivery Ltd Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
AU5871898A (en) * 1997-01-30 1998-08-25 Andaris Limited Microparticles and their use in cancer treatment
US6264988B1 (en) 1997-06-05 2001-07-24 Hemosphere, Inc. Fibrinogen-coated microspheres
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9724143D0 (en) 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ES2364636T3 (es) 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
CN1930190B (zh) * 2004-01-07 2011-04-20 生化学工业株式会社 透明质酸衍生物及含有其的药剂
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US7914999B2 (en) * 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
EP2216054A1 (en) 2009-02-06 2010-08-11 ProFibrix BV Biodegradable extravascular support
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
GB0909131D0 (en) 2009-05-28 2009-07-01 Quadrant Drug Delivery Ltd Dry powder fibrin sealant
WO2011083154A1 (en) 2010-01-08 2011-07-14 Profibrix Bv Dry powder fibrin sealant
NO20110653A1 (no) 2011-05-02 2012-11-05 Spiro Medical As Respirasjonsovervakning
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0494417T3 (da) * 1991-01-10 1996-05-13 Basf Corp Fremgangsmåde til tværbinding af gelatine og til inkorporering af et materiale deri
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents

Also Published As

Publication number Publication date
EP0796090A2 (en) 1997-09-24
PT796090E (pt) 2003-07-31
DE69529917D1 (de) 2003-04-17
CZ183797A3 (en) 1997-11-12
MX9704503A (es) 1997-10-31
CA2207077A1 (en) 1996-06-20
EP0796090B1 (en) 2003-03-12
JP4350165B2 (ja) 2009-10-21
WO1996018388A2 (en) 1996-06-20
FI972546A (fi) 1997-07-04
AU692019B2 (en) 1998-05-28
CA2207077C (en) 2007-02-06
AU4184996A (en) 1996-07-03
JPH10510527A (ja) 1998-10-13
ATE234080T1 (de) 2003-03-15
NZ297072A (en) 1999-03-29
NO972554D0 (no) 1997-06-05
DK0796090T3 (da) 2003-06-23
HUT77369A (hu) 1998-03-30
PL321018A1 (en) 1997-11-24
CN1175208A (zh) 1998-03-04
DE69529917T2 (de) 2003-12-11
FI972546A0 (fi) 1997-06-16
NO972554L (no) 1997-06-05
ZA9510702B (en) 1996-12-17
WO1996018388A3 (en) 1996-08-29
BR9510462A (pt) 1998-12-15

Similar Documents

Publication Publication Date Title
ES2191721T3 (es) Microparticulas reticuladas y su utilizacion como vehiculos terapeuticos.
WO2007079276A3 (en) Magnetic nanoscale particle compositions, and therapeutic methods related thereto
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
ATE204487T1 (de) Behandlung von untereinander vernetzten partikelaggregaten mit latex zur erhöhung der flexibilität von porösen absorbierenden makrostrukturen
MX9702357A (es) Microparticulas secadas por aspersion como vehiculos terapeuticos.
MY120109A (en) Disposable body fluid absorbent garment
SE9503926D0 (sv) Adsorptionsförfarande och separationsmedium
DE3883890D1 (de) Verfahren zur Herstellung eines Enzymgranulats.
ATE316815T1 (de) Kohlenstoffblock-wasserfilter
ES2195408T3 (es) Microparticulas perforadas y procedimientos de uso.
NO972814L (no) Forlenget-frigjöring granulære preparater og fremgangsmåte for fremstilling derav
ATE357924T1 (de) Adsorptionsmittel für die orale verabreichung, mittel zur behandlung oder prävention von nierenerkrankungen und mittel zur behandlung oder prävention von lebererkrankungen
ATE265204T1 (de) Micropartikeln zur verwendung in nadellosen injektion
ATE5235T1 (de) Flocken aus ionenaustauschharzen, ihre herstellung und ihre wiederbelebung und diese flocken verwendendes ionenaustausch- und filtrationsverfahren.
ES2190663T3 (es) Formulacion de un adhesivo de fibrina para tejidos y procedimiento para su fabricacion.
DE69725331D1 (de) Absorbierendes quellbares material aus vernetztem polyaspartat
FI20002216A0 (fi) Yhdistelmäpartikkelit astman hoitoon
ATE286081T1 (de) Verfahren zur herstellung von polymerteilchen
MX9603619A (es) Microparticulas que contienen gas, medios que contienen el ultimo, su uso en diagnosis ultrasonica, tambien como procesos para la produccion de las particulas y los medios.
Paul et al. Modified hydroxyapatite microspheres as immunoadsorbent for plasma perfusion: preliminary study
JPS5596095A (en) Composite particle group containing active protein substance * production * use and regeneration thereof
Lou et al. In-vivo and in-vitro targeting of a murine sarcoma by gelatin microparticles loaded with a glycan (PS1)
RU99106170A (ru) Способ профилактики и лечения гиперэндотоксинемии
TH10353EX (th) สารผสมควบคุมกลิ่นผสม
Maleev et al. The effect of toxic substances from St. aureus on the functional platelet properties.